Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654.

In fed rat livers perfused with [1-14C]oleic acid, Ro 22-0654 (4-amino-5-ethyl-3-thiophenecarboxylic acid methyl ester hydrochloride), an inhibitor of fatty acid synthesis, activated ketogenesis and decreased the secretion of triglyceride in very low density lipoproteins (VLDL). Ro 22-0654 was witho...

Full description

Bibliographic Details
Main Authors: M Yamamoto, N Fukuda, J Triscari, A C Sullivan, J A Ontko
Format: Article
Language:English
Published: Elsevier 1985-10-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S002222752034267X
_version_ 1818672247208935424
author M Yamamoto
N Fukuda
J Triscari
A C Sullivan
J A Ontko
author_facet M Yamamoto
N Fukuda
J Triscari
A C Sullivan
J A Ontko
author_sort M Yamamoto
collection DOAJ
description In fed rat livers perfused with [1-14C]oleic acid, Ro 22-0654 (4-amino-5-ethyl-3-thiophenecarboxylic acid methyl ester hydrochloride), an inhibitor of fatty acid synthesis, activated ketogenesis and decreased the secretion of triglyceride in very low density lipoproteins (VLDL). Ro 22-0654 was without effect on total oleic acid uptake and utilization by the liver. The liver triglyceride content, urea synthesis, and bile production were also unaffected. Ro 22-0654 increased the conversion of both exogenous and endogenous fatty acid substrates to ketone bodies, while decreasing the secretion of triglyceride synthesized from both of these sources. Depressed fatty acid synthesis accounted for a relatively small portion of the decrease in secretory triglyceride derived from endogenous sources. 14CO2 from [1-14C]oleic acid was unchanged by Ro 22-0654. This drug decreased the malonyl-CoA content of rat liver freeze-clamped in vivo, providing an explicable mechanism for its activation of fatty acid oxidation. Hepatic citrate was also diminished. The present studies indicate the following sequence of events in the liver of fed rats following the administration of Ro 22-0654: decreased formation of citrate and malonyl-CoA, decreased fatty acid synthesis via decreased carbon supply and increased fatty acid oxidation via stimulation of acylcarnitine formation, decreased synthesis of triglyceride from both endogenous and exogenous fatty acids, resulting in the decreased formation and secretion of VLDL.
first_indexed 2024-12-17T07:36:52Z
format Article
id doaj.art-44afc60e43fa4d1bb178b3d295c5563d
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-17T07:36:52Z
publishDate 1985-10-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-44afc60e43fa4d1bb178b3d295c5563d2022-12-21T21:58:18ZengElsevierJournal of Lipid Research0022-22751985-10-01261011961204Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654.M YamamotoN FukudaJ TriscariA C SullivanJ A OntkoIn fed rat livers perfused with [1-14C]oleic acid, Ro 22-0654 (4-amino-5-ethyl-3-thiophenecarboxylic acid methyl ester hydrochloride), an inhibitor of fatty acid synthesis, activated ketogenesis and decreased the secretion of triglyceride in very low density lipoproteins (VLDL). Ro 22-0654 was without effect on total oleic acid uptake and utilization by the liver. The liver triglyceride content, urea synthesis, and bile production were also unaffected. Ro 22-0654 increased the conversion of both exogenous and endogenous fatty acid substrates to ketone bodies, while decreasing the secretion of triglyceride synthesized from both of these sources. Depressed fatty acid synthesis accounted for a relatively small portion of the decrease in secretory triglyceride derived from endogenous sources. 14CO2 from [1-14C]oleic acid was unchanged by Ro 22-0654. This drug decreased the malonyl-CoA content of rat liver freeze-clamped in vivo, providing an explicable mechanism for its activation of fatty acid oxidation. Hepatic citrate was also diminished. The present studies indicate the following sequence of events in the liver of fed rats following the administration of Ro 22-0654: decreased formation of citrate and malonyl-CoA, decreased fatty acid synthesis via decreased carbon supply and increased fatty acid oxidation via stimulation of acylcarnitine formation, decreased synthesis of triglyceride from both endogenous and exogenous fatty acids, resulting in the decreased formation and secretion of VLDL.http://www.sciencedirect.com/science/article/pii/S002222752034267X
spellingShingle M Yamamoto
N Fukuda
J Triscari
A C Sullivan
J A Ontko
Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654.
Journal of Lipid Research
title Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654.
title_full Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654.
title_fullStr Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654.
title_full_unstemmed Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654.
title_short Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654.
title_sort decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by ro 22 0654
url http://www.sciencedirect.com/science/article/pii/S002222752034267X
work_keys_str_mv AT myamamoto decreasedhepaticproductionofverylowdensitylipoproteinsfollowingactivationoffattyacidoxidationbyro220654
AT nfukuda decreasedhepaticproductionofverylowdensitylipoproteinsfollowingactivationoffattyacidoxidationbyro220654
AT jtriscari decreasedhepaticproductionofverylowdensitylipoproteinsfollowingactivationoffattyacidoxidationbyro220654
AT acsullivan decreasedhepaticproductionofverylowdensitylipoproteinsfollowingactivationoffattyacidoxidationbyro220654
AT jaontko decreasedhepaticproductionofverylowdensitylipoproteinsfollowingactivationoffattyacidoxidationbyro220654